Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Clinical trial NCT02546102 · SUSPENDED

Trial details

NCT number: NCT02546102
Sponsor: Precision Life Sciences Group
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2024-12-01
Primary completion: 2025-12-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.